Sabal Trust CO increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 5.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 762 shares of the healthcare conglomerate’s stock after acquiring an additional 40 shares during the period. Sabal Trust CO’s holdings in UnitedHealth Group were worth $237,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of UNH. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 7.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock valued at $23,810,470,000 after acquiring an additional 5,654,194 shares during the last quarter. Fisher Asset Management LLC increased its holdings in shares of UnitedHealth Group by 41,127.3% during the 2nd quarter. Fisher Asset Management LLC now owns 2,347,070 shares of the healthcare conglomerate’s stock valued at $692,268,000 after acquiring an additional 2,341,377 shares during the last quarter. Nordea Investment Management AB grew its holdings in UnitedHealth Group by 103.1% in the 2nd quarter. Nordea Investment Management AB now owns 2,827,796 shares of the healthcare conglomerate’s stock valued at $817,176,000 after buying an additional 1,435,755 shares during the last quarter. GQG Partners LLC grew its holdings in UnitedHealth Group by 50.0% in the 2nd quarter. GQG Partners LLC now owns 2,105,870 shares of the healthcare conglomerate’s stock valued at $621,353,000 after buying an additional 702,164 shares during the last quarter. Finally, Two Sigma Advisers LP grew its holdings in UnitedHealth Group by 195.8% in the 2nd quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock valued at $224,339,000 after buying an additional 503,500 shares during the last quarter. 86.39% of the stock is currently owned by institutional investors and hedge funds.

In related news, EVP Marianne D. Short sold 12,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the completion of the sale, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Wednesday, July 22nd. The shares were sold at an average price of $303.50, for a total value of $3,035,000.00. Following the sale, the director now directly owns 159,215 shares of the company’s stock, valued at $48,321,752.50. The disclosure for this sale can be found here. Insiders have sold a total of 47,336 shares of company stock valued at $14,928,276 over the last ninety days. Insiders own 0.80% of the company’s stock.

A number of analysts have issued reports on UNH shares. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $293.00 to $312.00 and gave the company a “buy” rating in a report on Thursday, July 16th. Barclays raised their target price on UnitedHealth Group from $322.00 to $365.00 and gave the company an “overweight” rating in a report on Tuesday. Piper Sandler raised their target price on UnitedHealth Group from $350.00 to $385.00 and gave the company an “overweight” rating in a report on Thursday. Bank of America raised their target price on UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a report on Friday, August 28th. Finally, SVB Leerink raised their target price on UnitedHealth Group from $370.00 to $373.00 and gave the company an “outperform” rating in a report on Thursday. Four research analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $346.68.

UnitedHealth Group stock opened at $329.90 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.84 and a quick ratio of 0.84. The company has a market capitalization of $313.52 billion, a PE ratio of 18.55, a price-to-earnings-growth ratio of 1.44 and a beta of 0.68. UnitedHealth Group Inc has a one year low of $187.72 and a one year high of $333.70. The business has a 50 day simple moving average of $311.35 and a 200 day simple moving average of $297.69.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.98 by $0.53. The business had revenue of $65.12 billion during the quarter, compared to the consensus estimate of $63.97 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. UnitedHealth Group’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $3.88 EPS. Equities analysts anticipate that UnitedHealth Group Inc will post 16.58 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, September 11th. This represents a $5.00 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: How do analysts define an oversold condition?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.